Generics - Financial, Cardio-vascular

Filter

Current filters:

FinancialCardio-vascular

Popular Filters

1 to 25 of 2905 results

Eli Lilly 1st-qtr 2014 net income plunges, sales down, hit by generic competition

24-04-2014

US pharma major Eli Lilly posted first-quarter 2014 financial results, with revenue declined 16 % to…

Eli LillyFinancialPharmaceutical

Novartis 1st-qtr net profit flat, sales shy of forecasts

Novartis 1st-qtr net profit flat, sales shy of forecasts

24-04-2014

Swiss drug major Novartis posted a solid set of first-quarter 2014 financials this morning, showing that…

AlconFinancialNovartisPharmaceuticalSandoz

Biogen Idec 1st-qtr 2014 revenue leaps 51%, driven by Tecfidera and MS franchise

23-04-2014

US biotech firm Biogen Idec first-quarter 2014 results today, including revenue of $2.1 billion, a 51%…

Biogen IdecBiotechnologyFinancialNeurologicalResearchTecfidera

Abbott may acquire one of Russia’s leading drugmakers for $240 million

23-04-2014

The USA’s Abbott Laboratories is considering acquiring the 81.1 % stake in Veropharm, one of Russia’s…

Abbott LaboratoriesGenericsMergers & AcquisitionsRussiaVeropharm

Allergan adopts stockholder rights plan

23-04-2014

USA-based Allergan, the subject of a hostile takeover bid from Canada’s Valeant Pharmaceuticals reported…

AllerganFinancialMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals

Amgen's 1st-qtr 2014 disappoints, as net income falls 25%

23-04-2014

Amgen, the world’s largest independent biotech firm by revenues, yesterday announced financial results…

AmgenBiotechnologyFinancialResearch

Gilead 1st-qtr 2014 sales nearly double, fuelled by Sovaldi, as net income rockets

23-04-2014

US antivirals major Gilead Sciences posted first-quarter 2014 results after markets closed yesterday,…

Anti-viralsBiotechnologyFinancialGilead SciencesSovaldi

AbbVie files NDA for oral, interferon-free treatment of hepatitis C

22-04-2014

US drugmaker AbbVie has submitted its New Drug Application to the US Food and Drug Administration for…

AbbVieAnti-viralsEnanta PharmaceuticalsFinancialNorth AmericaPharmaceuticalRegulationUSA

Epizyme earns $4 million milestone under GSK collaboration

22-04-2014

US clinical-stage biopharma firm Epizyme announced the achievement of the lead candidate milestone for…

BiotechnologyEpizymeFinancialGlaxoSmithKlineLicensingOncology

AusBiotech to submit to Senate’s Australian innovation system inquiry

22-04-2014

Trade group AusBiotech is preparing a submission, following the Senate's referral of an inquiry into…

Asia-PacificAustraliaBiotechnologyFinancialResearch

Greek health system victim of debt crisis but reform now possible, say experts

22-04-2014

Greece's health care system was among the victims of the debt crisis which began four years ago, according…

EuropeFinancialGreeceHealthcarePharmaceuticalPolitics

NHS England agrees funding for Gilead’s hepatitis C drug Sovaldi

18-04-2014

NHS England has approved an £18.7 million ($31.3 million) investment in a new drug for the treatment…

Anti-viralsBiotechnologyFinancialGilead SciencesHealthcareNorthern EuropeSovaldiUK

Teva and Pfizer settle patent litigation over Celebrex

17-04-2014

Israel-based Teva Pharmaceutical Industries says that its US subsidiary has settled a law suit with US…

Anti-Arthritics/RheumaticsCelebrexGenericsNorth AmericaPatentsPfizerTeva Pharmaceutical IndustriesUSA

Heart Metabolics raises $20 million for Phase III heart disease drug trial

17-04-2014

Irish biotech company Heart Metabolics has completed a $20 million round of financing to support its…

BiotechnologyCardio-metabolic diseasesCardio-vascularDrug discoveryFinancialHeart diseaseHeart Metabolics LimitedIrelandPeter Milner

Actelion posts strong first-quarter 2014 results

Actelion posts strong first-quarter 2014 results

17-04-2014

Switzerland’s Actelion today announced financial results for the first three months of 2014, showing…

ActelionBiotechnologyFinancial

OxThera gains $10 million investment to continue Phase II trial

16-04-2014

Shareholders of privately-held Swedish biopharmaceutical company OxThera have agreed with a syndicate…

BiopharmaceuticalFinancialKidney diseasesOxabactOxTheraPharmaceuticalPrimary hyperoxaluriaRare diseasesRemi DrollerSweden

Johnson & Johnson 1st-qtr 2014 results beat expectations

Johnson & Johnson 1st-qtr 2014 results beat expectations

15-04-2014

US health care giant Johnson & Johnson today reported financial results for the first quarter of 2014,…

FinancialJohnson & JohnsonPharmaceutical

Prosonix and Mylan in deal for Flixotide and Flovent generics

15-04-2014

Prosonix, a UK-based company which is developing a portfolio of inhaled “Respiratory Medicines by Design,”…

FloventGenericsGlaxoSmithKlineGlobalLicensingMylan LaboratoriesProsonixRespiratory and Pulmonary

$5 million milestone for India’s Glenmark from Sanofi

$5 million milestone for India’s Glenmark from Sanofi

15-04-2014

Indian drugmaker Glenmark Pharmaceuticals says it has informed the Stock Exchange that it has received…

FinancialGlenmark PharmaceuticalsInflammatory diseasesPharmaceuticalResearchSanofi

1 to 25 of 2905 results

Back to top